-
EP0950417
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0950417
| EP0950417 - Treatment of skeletal disorders [Right-click to bookmark this link] | Status | The application has been refused Status updated on 24.10.2003 Database last updated on 06.07.2024 | Most recent event Tooltip | 24.10.2003 | Refusal of application | published on 10.12.2003 [2003/50] | Applicant(s) | For all designated states Pfizer Products Inc. Eastern Point Road Groton, CT 06340 / US | [N/P] |
| Former [1999/42] | For all designated states Pfizer Products Inc. Eastern Point Road Groton, Connecticut 06340 / US | Inventor(s) | 01 /
Ke, Hua Zhu 2 Deer Lane Ledyard, Connecticut 06339 / US | 02 /
Steppan, Claire Monica 142D Nautilus Drive New London, Connecticut 06320 / US | 03 /
Swick, Andrew Gordon 19 Spring Rock Road East Lyme, Connecticut 06333 / US | [1999/42] | Representative(s) | McMunn, Watson Palmer, et al Pfizer Limited Patents Department Ramsgate Road Sandwich, Kent CT13 9NJ / GB | [N/P] |
| Former [1999/42] | McMunn, Watson Palmer, et al Pfizer Limited Patents Department Ramsgate Road Sandwich, Kent CT13 9NJ / GB | Application number, filing date | 99301084.2 | 15.02.1999 | [1999/42] | Priority number, date | US19980075491 | 23.02.1998 Original published format: US 75491 | [1999/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0950417 | Date: | 20.10.1999 | Language: | EN | [1999/42] | Type: | A3 Search report | No.: | EP0950417 | Date: | 23.02.2000 | [2000/08] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 11.01.2000 | Classification | IPC: | A61K38/22, // (A61K38/22, 31:56),(A61K38/22, 31:135),(A61K38/22, 31:38),(A61K38/22, 31:40),(A61K38/22, 31:66) | [1999/42] | CPC: |
A61K38/2264 (EP,US);
A61P1/00 (EP);
A61P1/02 (EP);
A61P19/00 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P43/00 (EP)
(-)
| C-Set: |
A61K38/2264, A61K2300/00 (EP,US)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [2000/44] |
| Former [1999/42] | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE | Title | German: | Behandlung von Skeletterkrankungen | [1999/42] | English: | Treatment of skeletal disorders | [1999/42] | French: | Traitement d' anomalies du squelette | [1999/42] | Examination procedure | 01.03.1999 | Examination requested [1999/42] | 02.10.2001 | Despatch of a communication from the examining division (Time limit: M06) | 23.05.2002 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 24.07.2002 | Reply to a communication from the examining division | 26.09.2002 | Despatch of a communication from the examining division (Time limit: M04) | 23.01.2003 | Reply to a communication from the examining division | 23.06.2003 | Date of oral proceedings | 11.07.2003 | Despatch of communication that the application is refused, reason: substantive examination [2003/50] | 11.07.2003 | Minutes of oral proceedings despatched | 21.07.2003 | Application refused, date of legal effect [2003/50] | Request for further processing for: | 24.07.2002 | Request for further processing filed | 25.07.2002 | Full payment received (date of receipt of payment) Request granted | 12.08.2002 | Decision despatched | Fees paid | Renewal fee | 27.01.2001 | Renewal fee patent year 03 | 21.03.2002 | Renewal fee patent year 04 | 24.01.2003 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 28.02.2002 | 04 M06 Fee paid on 15.04.2002 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO9739767 (ZYMOGENETICS INC [US], et al) [X] 1-10,15,18-22 * page 1, line 32 - page 2, line 13 * * page 3, line 16 - page 4, line 2 * * page 6, line 36 - page 7, line 16 * * page 15, line 10 - line 28 * * page 18, line 22 - line 25 * * claims 12-17 * [Y] 11-14,16,17; | [Y]WO9731640 (PFIZER [US], et al) [Y] 11-14,16,17 * page 1, line 21 - page 2, line 29 * * page 14, line 1 - line 24 * * page 16, line 10 - page 22, line 9 *; | [XD]WO9718833 (AMGEN INC [US]) [XD] 1-8,18 * page 5, line 25 - line 28 * * page 25, line 5 - line 8 * * page 25, line 34 - line 36 * * claims 1,4 *; | [E]WO9953939 (MAYO FOUNDATION [US], et al) [E] 1-10,18-20,22 * claims 3,6-10 * |